Clinical trial
Personalized Exercise Training to Improve Functional Capacity in Transthyretin Cardiac Amyloidosis
NCT05797857 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Exercise Training to Improve Functional Capacity in Transthyretin Cardiac Amyloidosis
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 10, 2024
- Completion date
- June 30, 2030
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amyloid cardiomyopathy, transthyretin cardiac amyloidosis